SARCLISA 20mg/mL concentrate for solution for infusion.
APHP200067
Phase 2 small_molecule active
Quick answer
SARCLISA 20mg/mL concentrate for solution for infusion. for Pure cell red aplasia by major ABO mismatch after allogeneic hematopoietic stem cell transplantation is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Pure cell red aplasia by major ABO mismatch after allogeneic hematopoietic stem cell transplantation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active